Orlislim contains Orlistat. It inhibits gastric and pancreatic lipases, the enzyme responsible for breaking down triglycerides in the intestine. Thus reduces the subsequent absorption of monoaclglycerides and free fatty acids. It also decreases leptin and increases adiponectin independent of Body Fat which shows its anti-diabetic and anti-atherogenic properties and may help to prevent metabolic syndrome in the overweight persons. Thus Orlislim is indicated in weight Management.
